Compare Lenalidomide and Subcutaneous Daratumumab vs Lenalidomide and Dexamethasone in Frail Subjects With Previously Untreated Multiple Myeloma Who Are Ineligible for High Dose Therapy

Clinical trial NCT03993912 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03993912
Sponsor: University Hospital, Lille
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2019-10-17
Primary completion: 2026-10-07
Enrollment: 294

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.